Patrick

Develop et support cardiac lead extraction in France and medical devices infection awareness.

Philips to acquire for 1,9 B€ The Spectranetics Corporation to accelerate expansion in image-guided therapy devices to treat cardiac, medical device & peripheral vascular disease.

Responsabilities: Sales Manager half Western of France for Philips Image Guided Therapy Devices International:
• Business Development of cardiac leads extraction tools, Laser units and service contracts,
• Deployment of « out of the box » ideas. X projects build from scratch will be deploy still the end of 2022,
• Protect laser technology market and take market shares to competition with mechanical tools, increase sales and visibility.

Achievements:
- 2022 Best Sales Manager Heart Rhythm Management (Nominee)
- 2018 Best Sales Manager Heart Rhythm Management (Nominee)
- Executive education : Master of marketing in HEC, Paris.
- Professional thesis on reimbursement of Laser sheath in France : risks & opportunities.Develop et support cardiac lead extraction in France and medical devices infection awareness. Philips to acquire for 1,9 B€ The Spectranetics Corporation to accelerate expansion in image-guided therapy devices to treat cardiac, medical device & peripheral vascular disease. Responsabilities: Sales Manager half Western of France for Philips Image Guided Therapy Devices International: • Business Development of cardiac leads extraction tools, Laser units and service contracts, • Deployment of « out of the box » ideas. X projects build from scratch will be deploy still the end of 2022, • Protect laser technology market and take market shares to competition with mechanical tools, increase sales and visibility. Achievements: - 2022 Best Sales Manager Heart Rhythm Management (Nominee) - 2018 Best Sales Manager Heart Rhythm Management (Nominee) - Executive education : Master of marketing in HEC, Paris. - Professional thesis on reimbursement of Laser sheath in France : risks & opportunities.
Skills: Chirurgie cardiaque · Développement commercial · Finance

Spectranetics is now a part of Philips Image Guided Therapy Devices IGTD

Part of Lead management division, I promote medical devices like the lead extraction tools in Northern France (formely French speaking part of Switzerland) and support tricky extractions all over Western Europe.

• Devise strong business approach to 20+ major extraction centers in France and Switzerland.
• Trusted by KOLs, Cardiac surgeons and Electrophysiologists.
• Serve as a national project leader in developing new business and strategic partnerships to secure revenue growth and sustainability of the organisation’s business model.
• Excellent negotiation and communication skills to manage sales and drive profits.

We develop, manufacture, market and distribute single-use medical devices used in minimally invasive procedures within the cardiovascular system. The company’s products are sold in over 40 countries and are used to treat arterial blockages in the heart and legs as well as the removal of pacemaker and defibrillator leads.

The Lead Management (LM) product line includes excimer laser sheaths and cardiac lead management accessories for the removal of pacemaker and defibrillator cardiac leads.
There are more than 7 million pacemakers and implantable cardiac defibrillators (ICDs) implanted worldwide, 700,000 new devices implanted each year and 1.5 million new leads implanted annually.
These devices and the leads that connect them to the heart need ongoing management and maintenance. Sometimes this includes removal or replacement of the leads. Leads may need to be removed for a variety of reasons, including lead damage, lead or device infection, or manufacturer advisory.
Spectranetics is dedicated to safely managing every lead and providing state-of-the-art tools to ensure safe and precise removal.

SPNC Lead Management products are Bridge balloon, LLD, Laser Sheath, TightRail, SightRail, CVX-300 Laser system.

I was responsible for implementing the sales strategy & building the business of Endosense in Northern France, the Walloon Region of Belgium & Luxembourg.
Launch and sales of the new generation of the most exciting electrophysiology medical device for 10 years,
Developing the Endosense business in a new direct sales organization. Protection of the ASP.
Training and supporting cardiac electro-physiologists in the use of the first force sensing ablation catheter in the EP Lab.
Trainer & Certifier for advanced electrophysiology of Field Technician Engineers in France & Belgium.

August 2013 Endosense SA was acquired for total cash considerations of up to CHF309 million (USD331 million) by St. Jude Medical, Inc., a global medical device company (NYSE:STJ).
Abbott acquired St. Jude Medical in 2016.

Endosense SA is a medical device company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias.
Granted the CE mark in May 2009, Endosense SA’s TactiCath® is the first and only force-sensing ablation catheter to give physicians a real-time, objective measure of contact force during the catheter ablation procedure.
TactiCath® has undergone considerable preclinical and clinical testing, the results of which have created a solid foundation of evidence supporting the feasibility, safety and value of contact force sensing during catheter ablation.I was responsible for implementing the sales strategy & building the business of Endosense in Northern France, the Walloon Region of Belgium & Luxembourg. Launch and sales of the new generation of the most exciting electrophysiology medical device for 10 years, Developing the Endosense business in a new direct sales organization. Protection of the ASP. Training and supporting cardiac electro-physiologists in the use of the first force sensing ablation catheter in the EP Lab. Trainer & Certifier for advanced electrophysiology of Field Technician Engineers in France & Belgium. August 2013 Endosense SA was acquired for total cash considerations of up to CHF309 million (USD331 million) by St. Jude Medical, Inc., a global medical device company (NYSE:STJ). Abbott acquired St. Jude Medical in 2016. Endosense SA is a medical device company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias. Granted the CE mark in May 2009, Endosense SA’s TactiCath® is the first and only force-sensing ablation catheter to give physicians a real-time, objective measure of contact force during the catheter ablation procedure. TactiCath® has undergone considerable preclinical and clinical testing, the results of which have created a solid foundation of evidence supporting the feasibility, safety and value of contact force sensing during catheter ablation.
Skills: Start-up · Electrophysiologie cardiaque · Développement commercial

I was responsible for implementing the sales strategy & building the business of Endosense in Northern France, the Walloon Region of Belgium & Luxembourg.
Launch and sales of the new generation of the most exciting electrophysiology medical device for 10 years,
Developing the Endosense business in a new direct sales organization. Protection of the ASP.
Training and supporting cardiac electro-physiologists in the use of the first force sensing ablation catheter in the EP Lab.
Trainer & Certifier for advanced electrophysiology of Field Technician Engineers in France & Belgium.

August 2013 Endosense SA was acquired for total cash considerations of up to CHF309 million (USD331 million) by St. Jude Medical, Inc., a global medical device company (NYSE:STJ).
Abbott acquired St. Jude Medical in 2016.

Endosense SA is a medical device company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias.
Granted the CE mark in May 2009, Endosense SA’s TactiCath® is the first and only force-sensing ablation catheter to give physicians a real-time, objective measure of contact force during the catheter ablation procedure.
TactiCath® has undergone considerable preclinical and clinical testing, the results of which have created a solid foundation of evidence supporting the feasibility, safety and value of contact force sensing during catheter ablation.I was responsible for implementing the sales strategy & building the business of Endosense in Northern France, the Walloon Region of Belgium & Luxembourg. Launch and sales of the new generation of the most exciting electrophysiology medical device for 10 years, Developing the Endosense business in a new direct sales organization. Protection of the ASP. Training and supporting cardiac electro-physiologists in the use of the first force sensing ablation catheter in the EP Lab. Trainer & Certifier for advanced electrophysiology of Field Technician Engineers in France & Belgium. August 2013 Endosense SA was acquired for total cash considerations of up to CHF309 million (USD331 million) by St. Jude Medical, Inc., a global medical device company (NYSE:STJ). Abbott acquired St. Jude Medical in 2016. Endosense SA is a medical device company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias. Granted the CE mark in May 2009, Endosense SA’s TactiCath® is the first and only force-sensing ablation catheter to give physicians a real-time, objective measure of contact force during the catheter ablation procedure. TactiCath® has undergone considerable preclinical and clinical testing, the results of which have created a solid foundation of evidence supporting the feasibility, safety and value of contact force sensing during catheter ablation.
Skills: Start-up · Electrophysiologie cardiaque · Développement commercial

Training and technical support for Physiomed France (St Jude Medical, Schiller Medical and Holter Supplies).
Market analysis (Polysomnography, INR, BNP & TP biological diagnostics monitors).Training and technical support for Physiomed France (St Jude Medical, Schiller Medical and Holter Supplies). Market analysis (Polysomnography, INR, BNP & TP biological diagnostics monitors).
Skills: Défibrillateur automatique implantable (DAI) · Cardiac pacing · Polysomnographie · Cardiac holter · Entrepreneuriat

Medical devices sales: Pacemakers, ICD, CRT (heart failure) and electrophysiology (Diagnostic and RF ablation catheters).
Coordinated selling efforts for Cryoablation system and Ablation Frontier system.

2009 Award for the best growth in market share of pacemakers in France.
2010 Execution award for the launch of SureScan system.

Medical device sales: Pacemakers, CRT - Heart Failure (NewLiving CHF ancestor of the SonR CRT) electrophysiology diagnostic catheters and arrhythmia assessment devices for Paris area, Burgandy, Normandy and Picardy
2005-2006 Indenpendant Consultant for a quick conversion of Sorin Biomedica to Sorin Group market shares